Kjell M Tveit
Overview
Explore the profile of Kjell M Tveit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamfjord J, Myklebust T, Larsen I, Kure E, Glimelius B, Guren T, et al.
Cancer Epidemiol Biomarkers Prev
. 2021 Dec;
31(2):342-351.
PMID: 34853022
Background: Patients with right-sided colon cancer (RCC) and left-sided colon cancer (LCC) differ clinically and molecularly. The main objective was to investigate stage-stratified survival and recurrence of RCC and LCC...
2.
Olsen F, Jacobsen B, Heuch I, Tveit K, Balteskard L
BMC Health Serv Res
. 2021 Nov;
21(1):1272.
PMID: 34823515
Background: In 2015, cancer patient pathways (CPP) were implemented in Norway to reduce unnecessary non-medical delay in the diagnostic process and start of treatment. The main aim of this study...
3.
Tarpgaard L, Orum-Madsen M, Christensen I, Nordgaard C, Noer J, Guren T, et al.
Oncotarget
. 2016 Aug;
7(37):59441-59457.
PMID: 27509063
It is now widely accepted that therapeutic antibodies targeting epidermal growth factor receptor (EGFR) can have efficacy in KRAS wild-type advanced colorectal cancer (CRC) patients. What remains to be ascertained...
4.
Tarpgaard L, Christensen I, Hoyer-Hansen G, Lund I, Guren T, Glimelius B, et al.
Int J Cancer
. 2015 Feb;
137(10):2470-7.
PMID: 25664394
Circulating forms of the urokinase plasminogen activator receptor (uPAR) are associated with prognosis in patients with colorectal cancer. Preclinical studies have shown that uPAR can influence the state of phosphorylation...
5.
Asli L, Kvaloy S, Jetne V, Myklebust T, Levernes S, Tveit K, et al.
Int J Radiat Oncol Biol Phys
. 2014 Aug;
90(3):707-14.
PMID: 25160610
Purpose: To estimate actual utilization rates of radiation therapy (RT) in Norway, describe time trends (1997-2010), and compare these estimates with corresponding optimal RT rates. Methods And Materials: Data from...
6.
Dueland S, Guren T, Hagness M, Glimelius B, Line P, Pfeiffer P, et al.
Ann Surg
. 2014 Jun;
261(5):956-60.
PMID: 24950280
Objective: The primary objective was to compare overall survival (OS) in patients with colorectal cancer (CRC) with nonresectable liver-only metastases treated by liver transplantation or chemotherapy. Background: CRC is the...
7.
Kjersem J, Skovlund E, Ikdahl T, Guren T, Kersten C, Dalsgaard A, et al.
BMC Cancer
. 2014 Jun;
14:340.
PMID: 24884501
Background: Polymorphisms of genes encoding the Fcy receptors (Fc fragment of IgG receptor 2A (FCGR2A) and 3A (FCGR3A)), which influence their affinity for the Fc fragment, have been linked to...
8.
Hauglann B, Saltyte Benth J, Fossa S, Tveit K, Dahl A
Support Care Cancer
. 2014 May;
22(10):2821-30.
PMID: 24821364
Purpose: The study aims to investigate long-term development in annual labor income (ALI) among patients with colorectal cancer (CRC) compared to individually matched cancer-free controls. Methods: In a register-based cohort...
9.
Wiig J, Giercksky K, Tveit K
Acta Oncol
. 2014 Apr;
53(7):865-76.
PMID: 24678823
Background: Intraoperative radiotherapy (IORT) has been given for primary and locally recurrent rectal cancer for 30 years. Still, its effect is not clear. Material And Methods: PubMed and EMBASE search...
10.
Hauglann B, Saltyte Benth J, Fossa S, Tveit K, Dahl A
Acta Oncol
. 2013 Dec;
53(6):735-43.
PMID: 24345277
Purpose: To investigate long-term development of sickness absence and disability pension among colorectal cancer (CRC) survivors compared to matched cancer-free controls, and to assess to what degree socio-demographic and disease...